{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:09:24Z","timestamp":1790824164032,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["23K24116"],"award-info":[{"award-number":["23K24116"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Jikei University Graduate Research Fund"},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008670","name":"Terumo Foundation for Life Sciences and Arts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018662","name":"Mitsukoshi Health and Welfare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Ultrasonics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10396-025-01520-9","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T12:41:53Z","timestamp":1740832913000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pathological characteristics of inflammatory bowel diseases"],"prefix":"10.1007","volume":"52","author":[{"given":"Makoto","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Iwao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-6546","authenticated-orcid":false,"given":"Masayuki","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"1520_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","volume":"14","author":"LW Peterson","year":"2014","unstructured":"Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14:141\u201353.","journal-title":"Nat Rev Immunol"},{"key":"1520_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/imr.13396","volume":"326","author":"SH Light","year":"2024","unstructured":"Light SH, Nagler CR. Regulation of immune responses to food by commensal microbes. Immunol Rev. 2024;326:203\u201318.","journal-title":"Immunol Rev"},{"key":"1520_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307\u201317.","journal-title":"Nature"},{"key":"1520_CR4","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.3748\/wjg.v26.i28.3998","volume":"26","author":"YA Ghouri","year":"2020","unstructured":"Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel diseases. World J Gastroenterol. 2020;26:3998\u20134017.","journal-title":"World J Gastroenterol"},{"key":"1520_CR5","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012;380:1606\u201319.","journal-title":"Lancet"},{"key":"1520_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7861\/clinmed.2021-0080","volume":"21","author":"JP Segal","year":"2021","unstructured":"Segal JP, LeBlanc JF, Hart AL. Ulcerative colitis: an update. Clin Med (Lond). 2021;21:135\u20139.","journal-title":"Clin Med (Lond)"},{"key":"1520_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402:571\u201384.","journal-title":"Lancet"},{"key":"1520_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cgh.2022.10.004","volume":"21","author":"A Shirwaikar Thomas","year":"2023","unstructured":"Shirwaikar Thomas A, Hanauer S, Wang Y. Immune checkpoint inhibitor enterocolitis vs idiopathic inflammatory bowel disease. Clin Gastroenterol Hepatol. 2023;21:878\u201390.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1520_CR9","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/cas.14773","volume":"112","author":"T Kubo","year":"2021","unstructured":"Kubo T, Hirohashi Y, Keira Y, et al. Identification of characteristic subepithelial surface granulomatosis in immune-related adverse event-associated enterocolitis. Cancer Sci. 2021;112:1320\u20135.","journal-title":"Cancer Sci"},{"key":"1520_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/BF02347623","volume":"31","author":"M Okada","year":"1996","unstructured":"Okada M, Maeda K, Yao T, et al. Right-sided ulcerative colitis. J Gastroenterol. 1996;31:717\u201322.","journal-title":"J Gastroenterol"},{"key":"1520_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1309\/UAXMW3428PGN9HJ3","volume":"126","author":"N Goldstein","year":"2006","unstructured":"Goldstein N, Dulai M. Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn disease. Am J Clin Pathol. 2006;126:365\u201376.","journal-title":"Am J Clin Pathol"},{"key":"1520_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0016-5085(58)80002-5","volume":"34","author":"G Lumb","year":"1958","unstructured":"Lumb G, Protheroe RH. Ulcerative colitis; a pathologic study of 152 surgical specimens. Gastroenterology. 1958;34:381\u2013407.","journal-title":"Gastroenterology"},{"key":"1520_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/ajcp\/40.6.610","volume":"40","author":"SL Saltzstein","year":"1963","unstructured":"Saltzstein SL, Rosenberg BF. Ulcerative colitis of the ileum and regional enteritis of the colon. Am J Clin Pathol. 1963;40:610\u201323.","journal-title":"Am J Clin Pathol"},{"key":"1520_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3109\/00365529409094843","volume":"29","author":"G Schumacher","year":"1994","unstructured":"Schumacher G, Kollberg B, Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol. 1994;29:318\u201332.","journal-title":"Scand J Gastroenterol"},{"key":"1520_CR15","first-page":"763","volume":"63","author":"Y Ajioka","year":"2005","unstructured":"Ajioka Y, Nishikura K. Watanabe G [Pathomorphology of ulcerative colitis]. Nihon Rinsho. 2005;63:763\u20139.","journal-title":"Nihon Rinsho"},{"key":"1520_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/PAP.0000000000000325","volume":"29","author":"B K\u0151v\u00e1ri","year":"2022","unstructured":"K\u0151v\u00e1ri B, B\u00e1thori \u00c1, Friedman MS, et al. Histologic diagnosis of inflammatory bowel diseases. Adv Anat Pathol. 2022;29:48\u201361.","journal-title":"Adv Anat Pathol"},{"key":"1520_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/BF00210236","volume":"70","author":"C Rozenbajgier","year":"1992","unstructured":"Rozenbajgier C, Ruck P, Jenss H, et al. Filiform polyposis: a case report describing clinical, morphological, and immunohistochemical findings. Clin Investig. 1992;70:520\u20138.","journal-title":"Clin Investig"},{"issue":"845\u20136","key":"1520_CR18","first-page":"848","volume":"38","author":"KJ Bauknecht","year":"2000","unstructured":"Bauknecht KJ, Grosse G, Kleinert J, et al. Filiform polyposis of the colon in chronic inflammatory bowel disease (so-called giant inflammatory polyps). Z Gastroenterol. 2000;38(845\u20136):848\u201354.","journal-title":"Z Gastroenterol"},{"key":"1520_CR19","first-page":"601","volume":"48","author":"T Yao","year":"2013","unstructured":"Yao T, Iihara K. Histopathological diagnosis of inflammatory bowel disease. Stomach and Intestine (Tokyo). 2013;48:601\u201310.","journal-title":"Stomach and Intestine (Tokyo)"},{"key":"1520_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ibd.21847","volume":"18","author":"DM Autenrieth","year":"2012","unstructured":"Autenrieth DM, Baumgart DC. Toxic megacolon. Inflamm Bowel Dis. 2012;18:584\u201391.","journal-title":"Inflamm Bowel Dis"},{"key":"1520_CR21","first-page":"489","volume":"43","author":"S Haraoka","year":"2008","unstructured":"Haraoka S, Iwashita A. Pathological differential diagnosis of inflammatory diseases of the small intestine. Stomach and Intestine (Tokyo). 2008;43:489\u201397.","journal-title":"Stomach and Intestine (Tokyo)"},{"key":"1520_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/1346-8138.14034","volume":"45","author":"T Fukumoto","year":"2018","unstructured":"Fukumoto T, Fujiwara S, Tajima S, et al. Infliximab for severe colitis associated with nivolumab followed by ipilimumab. J Dermatol. 2018;45:e1\u20132.","journal-title":"J Dermatol"},{"key":"1520_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40425-018-0411-1","volume":"6","author":"H Abu-Sbeih","year":"2018","unstructured":"Abu-Sbeih H, Ali FS, Luo W, et al. Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis. J Immunother Cancer. 2018;6:95.","journal-title":"J Immunother Cancer"},{"key":"1520_CR24","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/ibd\/izy104","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang Y, Abu-Sbeih H, Mao E, et al. Endoscopic and histologic features of immune checkpoint inhibitor-related colitis. Inflamm Bowel Dis. 2018;24:1695\u2013705.","journal-title":"Inflamm Bowel Dis"},{"key":"1520_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/den.13555","volume":"32","author":"S Yanai","year":"2020","unstructured":"Yanai S, Nakamura S, Kawasaki K, et al. Immune checkpoint inhibitor-induced diarrhea: clinicopathological study of 11 patients. Dig Endosc. 2020;32:616\u201320.","journal-title":"Dig Endosc"},{"key":"1520_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.gtc.2021.12.006","volume":"51","author":"S Gupta","year":"2022","unstructured":"Gupta S, Allegretti JR. Mimics of Crohn\u2019s disease. Gastroenterol Clin North Am. 2022;51:241\u201369.","journal-title":"Gastroenterol Clin North Am"},{"key":"1520_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11894-010-0112-5","volume":"12","author":"S Dilauro","year":"2010","unstructured":"Dilauro S, Crum-Cianflone NF. Ileitis: when it is not Crohn\u2019s disease. Curr Gastroenterol Rep. 2010;12:249\u201358.","journal-title":"Curr Gastroenterol Rep"},{"key":"1520_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152608","volume":"216","author":"H Wang","year":"2020","unstructured":"Wang H, Kanthan R. Multiple colonic and ileal perforations due to unsuspected intestinal amoebiasis\u2014case report and review. Pathol Res Pract. 2020;216: 152608.","journal-title":"Pathol Res Pract"},{"key":"1520_CR29","first-page":"951","volume":"41","author":"S Shimizu","year":"2006","unstructured":"Shimizu S, Watanabe M, Tomioka H, et al. Infectious diseases which should be differentiated from Crohn\u2019s disease. Stomach and Intestine (Tokyo). 2006;41:951\u20138.","journal-title":"Stomach and Intestine (Tokyo)"},{"key":"1520_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","volume":"19","author":"DB Johnson","year":"2022","unstructured":"Johnson DB, Nebhan CA, Moslehi JJ, et al. Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol. 2022;19:254\u201367.","journal-title":"Nat Rev Clin Oncol"},{"key":"1520_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.clcc.2023.12.003","volume":"23","author":"K Mok","year":"2024","unstructured":"Mok K, Wu C, Chan S, et al. Clinical management of gastrointestinal and liver toxicities of immune checkpoint inhibitors. Clin Colorectal Cancer. 2024;23:4\u201313.","journal-title":"Clin Colorectal Cancer"},{"key":"1520_CR32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jamaoncol.2019.1022","volume":"5","author":"A Simonaggio","year":"2019","unstructured":"Simonaggio A, Michot JM, Voisin AL, et al. Evaluation of readministration of immune checkpoint inhibitors after immune-related adverse events in patients with cancer. JAMA Oncol. 2019;5:1310\u20137.","journal-title":"JAMA Oncol"},{"key":"1520_CR33","first-page":"891","volume":"55","author":"S Yanai","year":"2020","unstructured":"Yanai S, Nakamura S, Kawasaki K, et al. Clinical and colonoscopic features of immune checkpoint inhibitor-associated colitis. Stomach Intestine (Tokyo). 2020;55:891\u20139.","journal-title":"Stomach Intestine (Tokyo)"},{"key":"1520_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/his.13118","volume":"70","author":"RS Gonzalez","year":"2017","unstructured":"Gonzalez RS, Salaria SN, Bohannon CD, et al. PD-1 inhibitor gastroenterocolitis: case series and appraisal of \u2018immunomodulatory gastroenterocolitis.\u2019 Histopathology. 2017;70:558\u201367.","journal-title":"Histopathology"},{"key":"1520_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/PAS.0000000000000829","volume":"41","author":"JH Chen","year":"2017","unstructured":"Chen JH, Pezhouh MK, Lauwers GY, et al. Histopathologic features of colitis due to immunotherapy with anti-PD-1 antibodies. Am J Surg Pathol. 2017;41:643\u201354.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR36","first-page":"883","volume":"55","author":"T Yao","year":"2020","unstructured":"Yao T, Okano S, Takeda T, et al. Histopathological features of drug-related digestive diseases. Stomach Intestine (Tokyo). 2020;55:883\u20139.","journal-title":"Stomach Intestine (Tokyo)"},{"key":"1520_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/apt.13281","volume":"42","author":"A Gupta","year":"2015","unstructured":"Gupta A, De Felice KM, et al. Systematic review: colitis associated with anti-CTLA-4 therapy. Aliment Pharmacol Ther. 2015;42:406\u201317.","journal-title":"Aliment Pharmacol Ther"},{"key":"1520_CR38","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s10620-020-06441-w","volume":"66","author":"Y Hayashi","year":"2021","unstructured":"Hayashi Y, Hosoe N, Takabayashi K, et al. Clinical, endoscopic, and pathological characteristics of immune checkpoint inhibitor-induced gastroenterocolitis. Dig Dis Sci. 2021;66:2129\u201334.","journal-title":"Dig Dis Sci"},{"key":"1520_CR39","first-page":"18","volume":"37","author":"M Tanaka","year":"1990","unstructured":"Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn\u2019s disease. Hepatogastroenterology. 1990;37:18\u201331.","journal-title":"Hepatogastroenterology"},{"key":"1520_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/003655200750024155","volume":"35","author":"M Tanaka","year":"2000","unstructured":"Tanaka M, Saito H, Fukuda S, et al. Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity. Scand J Gastroenterol. 2000;35:281\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"1520_CR41","first-page":"2267","volume":"48","author":"M Tanaka","year":"2006","unstructured":"Tanaka M. Pathological diagnosis of inflammatory bowel disease. Gastroenterol Endosc. 2006;48:2267\u201376.","journal-title":"Gastroenterol Endosc"},{"key":"1520_CR42","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00054725-200309000-00007","volume":"9","author":"K Geboes","year":"2003","unstructured":"Geboes K, De Hertogh G. Indeterminate colitis. Inflamm Bowel Dis. 2003;9:324\u201331.","journal-title":"Inflamm Bowel Dis"},{"key":"1520_CR43","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/jcp.2003.015214","volume":"57","author":"M Guindi","year":"2004","unstructured":"Guindi M, Riddell RH. Indeterminate colitis. J Clin Pathol. 2004;57:1233\u201344.","journal-title":"J Clin Pathol"},{"key":"1520_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000501519","volume":"4","author":"LE Thurgate","year":"2019","unstructured":"Thurgate LE, Lemberg DA, Day AS, et al. An overview of inflammatory bowel disease unclassified in children. Inflamm Intest Dis. 2019;4:97\u2013103.","journal-title":"Inflamm Intest Dis"},{"key":"1520_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40272-017-0213-9","volume":"19","author":"G D\u2019Arcangelo","year":"2017","unstructured":"D\u2019Arcangelo G, Aloi M. Inflammatory bowel disease-unclassified in children: diagnosis and pharmacological management. Paediatr Drugs. 2017;19:113\u201320.","journal-title":"Paediatr Drugs"},{"key":"1520_CR46","doi-asserted-by":"publisher","first-page":"5A","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A-36A.","journal-title":"Can J Gastroenterol"},{"key":"1520_CR47","unstructured":"Shimizu S, Tomioka H, Ogiso K, et al. Indeterminate colitis and inflammatory bowel disease unclassified. ENDOSCOPIA DIGESTIVA (Japan). 2020;32:276\u201381."},{"key":"1520_CR48","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/gut.48.4.526","volume":"48","author":"JA Eaden","year":"2001","unstructured":"Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526\u201335.","journal-title":"Gut"},{"key":"1520_CR49","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00000441-192508010-00006","volume":"170","author":"BB Crohn","year":"1925","unstructured":"Crohn BB, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci. 1925;170:220\u20138.","journal-title":"Am J Med Sci"},{"key":"1520_CR50","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","volume":"323","author":"A Ekbom","year":"1990","unstructured":"Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228\u201333.","journal-title":"N Engl J Med"},{"key":"1520_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.gtc.2006.07.008","volume":"35","author":"S Friedman","year":"2006","unstructured":"Friedman S. Cancer in Crohn\u2019s disease. Gastroenterol Clin North Am. 2006;35:621\u201339.","journal-title":"Gastroenterol Clin North Am"},{"key":"1520_CR52","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/17474124.2018.1500175","volume":"12","author":"T Yamamoto","year":"2018","unstructured":"Yamamoto T, Kotze PG, Spinelli A, et al. Fistula-associated anal carcinoma in Crohn\u2019s disease. Expert Rev Gastroenterol Hepatol. 2018;12:917\u201325.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1520_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ibd.20267","volume":"14","author":"T Matsumoto","year":"2008","unstructured":"Matsumoto T, Iwao Y, Igarashi M, et al. Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis. 2008;14:259\u201364.","journal-title":"Inflamm Bowel Dis"},{"key":"1520_CR54","first-page":"1464","volume":"49","author":"Y Iwao","year":"2014","unstructured":"Iwao Y, Shimoda M, Sugino Y, et al. Diagnosis of ulcerative colitis-associated intraepithelial neoplasia using magnifying endoscopy. Stomach Intestine (Tokyo). 2014;49:1464\u201378.","journal-title":"Stomach Intestine (Tokyo)"},{"key":"1520_CR55","doi-asserted-by":"publisher","first-page":"E552","DOI":"10.1055\/a-1352-2709","volume":"9","author":"A Ikebata","year":"2021","unstructured":"Ikebata A, Shimoda M, Okabayashi K, et al. Demarcated redness associated with increased vascular density\/size: a useful marker of flat-type dysplasia in patients with ulcerative colitis. Endosc Int Open. 2021;9:E552\u201361.","journal-title":"Endosc Int Open"}],"container-title":["Journal of Medical Ultrasonics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10396-025-01520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10396-025-01520-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10396-025-01520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T09:03:52Z","timestamp":1745399032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10396-025-01520-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1520"],"URL":"https:\/\/doi.org\/10.1007\/s10396-025-01520-9","relation":{},"ISSN":["1346-4523","1613-2254"],"issn-type":[{"value":"1346-4523","type":"print"},{"value":"1613-2254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interst"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}